Human-derived fusogenic peptides for the intracellular delivery of proteins

2017 ◽  
Vol 255 ◽  
pp. 1-11 ◽  
Author(s):  
Kei Sudo ◽  
Keisuke Niikura ◽  
Kouta Iwaki ◽  
Shunshi Kohyama ◽  
Kei Fujiwara ◽  
...  
Biopolymers ◽  
2008 ◽  
Vol 89 (10) ◽  
pp. 881-888 ◽  
Author(s):  
Hyejung Mok ◽  
Tae Gwan Park

Processes ◽  
2021 ◽  
Vol 9 (2) ◽  
pp. 224
Author(s):  
Ikuhiko Nakase

We previously reported that macropinocytosis (accompanied by actin reorganization, ruffling of the plasma membrane, and engulfment of large volumes of extracellular fluid) is an important process for the cellular uptake of extracellular vesicles, exosomes. Accordingly, we developed techniques to induce macropinocytosis by the modification of biofunctional peptides on exosomal membranes, thereby enhancing their cellular uptake. Arginine-rich cell-penetrating peptides have been shown to induce macropinocytosis via proteoglycans; accordingly, we developed peptide-modified exosomes that could actively induce macropinocytotic uptake by cells. In addition, the activation of EGFR induces macropinocytosis; based on this knowledge, we developed artificial leucine-zipper peptide (K4)-modified exosomes. These exosomes can recognize E3 sequence-fused EGFR (E3-EGFR), leading to the clustering and activation of E3-EGFR by coiled-coil formation (E3/K4), which induces cellular exosome uptake by macropinocytosis. In addition, modification of pH-sensitive fusogenic peptides (e.g., GALA) also enhances the cytosolic release of exosomal contents. These experimental techniques and findings using biofunctional peptides have contributed to the development of exosome-based intracellular delivery systems.


2019 ◽  
Author(s):  
Rohit Bhadoria ◽  
Kefeng Ping ◽  
Christer Lohk ◽  
Ivar Järving ◽  
Pavel Starkov

<div> <div> <div> <p>Conjugation techniques are central to improving intracellular delivery of bioactive small molecules. However, tracking and assessing the overall biological outcome of these constructs remains poorly understood. We addressed this issue by having developed a focused library of heterobivalent constructs based on Rho kinase inhibitors to probe various scenarios. By comparing induction of a phenotype of interest vs. cell viability vs. cellular uptake, we demonstrate that such conjugates indeed lead to divergent cellular outcomes. </p> </div> </div> </div>


2007 ◽  
Vol 3 (4) ◽  
pp. 329-338 ◽  
Author(s):  
Yah-el Har-el ◽  
Yoshinori Kato

Author(s):  
Max E. Distler ◽  
Michelle H. Teplensky ◽  
Katherine E. Bujold ◽  
Caroline D. Kusmierz ◽  
Michael Evangelopoulos ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document